Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 01, 2017 07:00 ET | Source: Forward Pharma A/S

Forward Pharma Board of Directors Approves Capital Reduction and Returns EUR 917.7 Million to Shareholders

COPENHAGEN, Denmark, Sept. 01, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“the Company” or “Forward”) today announced the final approval by the Company’s board of directors of the...
August 02, 2017 16:45 ET | Source: Forward Pharma A/S

Forward Pharma Obtains Shareholder Approval of the Planned Capital Reduction at the Extraordinary General Meeting

COPENHAGEN, Denmark, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“the Company” or “Forward”) today announced the result of the extraordinary general meeting of its...
July 18, 2017 08:05 ET | Source: Forward Pharma A/S

Forward Pharma announces planned distribution of EUR 19.45 per share to Shareholders

COPENHAGEN, Denmark, July 18, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“the Company” or “Forward”) today announced plans to return EUR 19.45 per share amounting to a total of EUR...
June 14, 2017 08:00 ET | Source: Forward Pharma A/S

Forward Pharma CEO to Present at the JMP Securities 2017 Life Sciences Conference on June 20, 2017

COPENHAGEN, Denmark, June 14, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will present...
June 02, 2017 08:30 ET | Source: Forward Pharma A/S

Forward Pharma CEO to Present at the Jefferies 2017 Global Healthcare Conference on June 6, 2017

COPENHAGEN, Denmark, June 02, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will present...
May 31, 2017 08:30 ET | Source: Forward Pharma A/S

Forward Pharma Appeals the Initial Decision in the U.S. Patent Interference to the Federal Circuit

COPENHAGEN, Denmark, May 31, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced the filing of the notice of appeal of the PTAB decision that ended...
May 01, 2017 08:30 ET | Source: Forward Pharma A/S

Forward Pharma CEO to Present at the 42nd Annual Deutsche Bank Health Care Conference on May 4, 2017

COPENHAGEN, Denmark, May 01, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will present...
May 01, 2017 07:30 ET | Source: Forward Pharma A/S

Forward Pharma Further Aligns Cost Structure with Focus Following Settlement and License Agreement

COPENHAGEN, Denmark, May 01, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward” or the “Company”) today provided an update on the Company’s strategic focus and related...
April 18, 2017 17:15 ET | Source: Forward Pharma A/S

Forward Pharma Reports Fourth Quarter and Year End 2016 Financial and Operational Results

COPENHAGEN, Denmark, April 18, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward” or the “Company”), today reported financial results for the fourth quarter and year ended...
March 31, 2017 18:59 ET | Source: Forward Pharma A/S

Forward Pharma Intends to Appeal Decision in Patent Interference Proceeding with Biogen Inc.

COPENHAGEN, Denmark, March 31, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (FWP) (“Forward Pharma” or the “Company”), a biopharmaceutical company that commenced development in 2005 of FP187, a...